TORONTO, ONTARIO--(Marketwire - March 14, 2011) - Theralase Technologies Inc. (TSX VENTURE:TLT) announced today that it has successfully launched its US and Canadian sales and marketing strategy to drive sales of its proprietary super-pulsed laser technology, utilized in healing neural muscular skeletal conditions in humans, cats, dogs and horses.
Under the new strategy, Canada will be subdivided into the West, Central and East divisions, while the United States will be subdivided into the Mid West, North East, South West, South Central and South East divisions. In order to extend Theralase's reach and help meet North American demand, each geographical region will be controlled by a Territory Sales Manager (TSM), an employee of Theralase, responsible for the sale of Theralase products in their respective territories.
"By segmenting the Canadian and US markets and hiring new Territory Sales Managers, we can utilise dedicated sales personnel to meet increasing demand and better service our existing clients," said Roger Dumoulin-White, President and CEO, Theralase. "We are confident our new strategy will help Theralase expand into the larger US market and significantly increase the sale of our medical lasers in 2011 and beyond."
Four of the eight TSMs have been hired and the firm is in the process of hiring four more prior to March 31, 2011, all of whom will report directly to the National Sales Manager Scott Bleue.
New Hires to Meet North American Demand
- Lance Arianna will head up the US South Central territory. Based out of Dallas, Texas, Mr. Arianna brings over 20 years of medical sales experience to the table selling medical lasers, capital medical equipment and pharmaceuticals.
- Gary Kazimer will head up the Western Canada territory. Based out of Calgary, Alberta, Mr. Kazimer has over 22 years of medical sales experience in the area of medical diagnostic equipment and has sold lasers into both the opthalmic and aesthetic medical markets in Western Canada.
- Marino Ricci will head up the Eastern Canada territory. Based in Ottawa, Ontario, Mr. Ricci is fully bilingual and has been selling medical devices, lasers and aesthetic products into the Quebec and Maritimes market for more than 8 years.
- James Vaughn will head up the US North East territory. Based out of Long Island, New York, Mr. Vaughn has over 13 years of medical sales experience and over 10 years selling capital medical equipment, including medical lasers, into New York area hospitals and private medical practices.
"We are delighted to have attracted such high quality sales professionals to our organization," said Scott Bleue, National Sales Manager of Theralase. "I am confident that Lance, James, Gary and Marino will all prove to be extremely effective in their new roles as the company spreads its wings to expand both north and south of the border. We look forward to adding more personnel to our sales team by the end of the first quarter in 2011."
Visit the corporate or regulatory website at www.theralase.com or www.sedar.com for more information.
About Theralase Technologies Inc.
Theralase Technologies Inc. designs, develops and manufactures patented, super-pulsed laser technology utilized in bio-stimulation and bio-destruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with patented light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria and viruses.
This press release contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.